adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2, covering 2022-09-12 to 2022-09-12. Get the full timeline:
Most recent: Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval